Jianguo Xu
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
HMMR inhibition by 4-methylumbelliferone is effective in preclinical hepatocellular carcinoma models.
Journal: Histology and histopathology
Published: May 29, 2025
USP3 inhibition is Active Against Chemo-resistant Hepatocellular Carcinoma Anchorage-independent Growth via Suppressing Wnt/β-catenin.
Journal: Current molecular medicine
Published: May 24, 2023
Characteristics of gut microbiota in patients with metabolic associated fatty liver disease.
Journal: Scientific reports
Published: March 03, 2023
Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid.
Journal: European journal of clinical investigation
Published: August 11, 2021
Discovery and validation of novel protein markers in mucosa of portal hypertensive gastropathy.
Journal: BMC gastroenterology
Published: January 29, 2021
T-bet transduction enhances anti-tumor efficacy of IFN-producing dendritic cell (IKDC) against hepatocellular carcinoma via apoptosis induction.
Journal: Biochemical and biophysical research communications
Published: November 26, 2020
Evaluation of blue laser endoscopy for detecting colorectal non-pedunculated adenoma.
Journal: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology
Published: May 10, 2020
TFAM depletion overcomes hepatocellular carcinoma resistance to doxorubicin and sorafenib through AMPK activation and mitochondrial dysfunction.
Journal: Gene
Published: November 14, 2019
ICMT contributes to hepatocellular carcinoma growth, survival, migration and chemoresistance via multiple oncogenic pathways.
Journal: Biochemical and biophysical research communications
Published: August 08, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026